Luxurious product background with soft lighting

Skincare backed with research

ISB-HC02

Patent Registration 10-2023-169400

The Future of Skin Science

We derive our skincare technology from Allogeneic Myocardium-Derived Adult Stem Cell Extracellular Vesicles. The technology of allogenic myocardium-derived stem cells was originally targeted to use as a treatment for patients with rheumatoid arthritis, Duchenne muscular dystrophy, autoimmune and neurodegenerative diseases. When applied to skincare, the extracellular vesicles (HC02) from myocardium-derived adult stem cells have potential to innovate skincare paradigm. We aim to resolve dermatological problems not just on a surface level, but by targeting molecular mechanisms of the skin and resolving the core issue.

High-end skincare product bottle with minimalist design

The Technology Behind Our Skincare

High-Purity

Advanced Isolation Technology

High-purity, high-efficiency biopharmaceutical production. 3D, homeostasis-mimicking culture.

3-Year Stability

Ready-to-Inject Freezing Formula

A stable, long-shelf-life formula for consistent efficacy.

The science behind our skincare

Multimodal mechanism of action of MyoCSC

01

Anti-inflammation and Immune Modulation

Effects

  • Calming effect on the skin & inhibits melanin production
  • Fine-tones the skin

Mechanisms

  • Anti-inflammation: IL-6 and miR-146a for inducing M1-M2 polarization
  • Immune modulation: IDO, PGE2 and miR-146a to suppress Th1/Th17 response, induce Th2 response
Anti-inflammation and Immune Modulation
02

Extracellular Matrix Remodeling

Effects

  • Anti-aging effect, collagen synthesis, strengthens skin barrier

Mechanisms

  • Indirect angiogenesis: Ang-1, HGF, SDF-1, VEGF
Extracellular Matrix Remodeling
03

Angiogenesis & Wound Healing

Effects

  • Stimulates fibroblast growth and collagen synthesis
  • Skin regeneration & anti-aging effect

Mechanisms

  • Anti-apoptosis/wound healing: SDF-1, IL-6, HGF for recruiting endogenous stem cells
Angiogenesis & Wound Healing

Proven Efficacy

1.Angiogenesis

Quantity and Time-dependent growth

Figure 1. Dose-dependent increases in vascular sprouting length were observed with HC02, consistent across all manufacturing lots. Figure 2. The structural integrity of the sprouting was maintained throughout the culture period when HC02 was administered.

Angiogenesis image 1

Figure 1

Angiogenesis image 2

Figure 2

2.Induction of dermal fibroblast growth

Figure 3. The ability of HC02 to induce cell growth was demonstrated by the increase in cell density according to the concentration of HC02 added during the culture of dermal fibroblasts in human skin.

Induction of dermal fibroblast growth

Figure 3

3.Regeneration of muscle fiber & Anti-inflammation

Decreased activity of caspase regulates apoptosis and inflammation.

Figure 4. In the Ischemic Hindlimb Mouse Model, administration of HC02 shows tissue/cell protective effects by inhibiting the activity of Caspase 3/7, an apoptosis-related protein that increases during muscle necrosis and damage.

Regeneration of muscle fiber & Anti-inflammation

Figure 4